中文 | English
Return
Total: 55 , 1/6
Show Home Prev Next End page: GO
Author:(Xiaoting HE)

1.MicroRNA and cancer

Xiaoting HE

Journal of International Oncology 2010;37(12):883-885

2.Expression and clinical significance of CCNG2 in glioblastoma pa-tients

Xianglong CHEN ; Kefei HE ; Xiaoting CHEN

Chinese Journal of Clinical Oncology 2014;46(4):237-241

3.Galectin-3 and Tumour Metastasis

Zhiming YANG ; Xiaoting WU ; Tao HE

Chinese Journal of Bases and Clinics in General Surgery 2003;0(03):-

4.Research Progression of Molecular Mechanism of Peritoneal Dissemination of Gastric Cancer

Tao HE ; Zhiming YANG ; Xiaoting WU ;

Chinese Journal of Bases and Clinics in General Surgery 2004;0(01):-

5.Invance sling in treating children incontinence as neurogenic sphincteric incompetence (report of 2 cases)

Huixu HE ; Weilie HU ; Xiaoting HUANG

Chinese Journal of Urology 2001;0(06):-

6.miR-205 inhibits invasion of glioma cells via targeting TBX18

Guopei ZHENG ; Xiaoting JIA ; Cong PENG ; Zhimin HE

Chinese Journal of Pathophysiology 2015;(7):1219-1224

7.miR-126-mediated activation of IGF2/IGF1R/IRS1 signaling promotes the Herceptin resistance in ErbB2 positive breast cancer cells

Liyun LUO ; Xiaoting JIA ; Guopei ZHENG ; Zhimin HE

Journal of Chinese Physician 2017;19(2):163-167

8.FGF2 confers chemo-resistance of breast cancer cells by activating Akt-mTOR signal

Yixue GU ; Xiaoting JIA ; Liyun LUO ; Guopei ZHENG ; Zhimin HE

The Journal of Practical Medicine 2017;33(1):36-40

9.Pharmacokinetic interaction between sunitinib and ramipril in rats

Yuhao WANG ; Xue ZHANG ; Xiaoting ZHOU ; Hua HE ; Xiaoquan LIU

Journal of China Pharmaceutical University 2017;48(1):60-65

10.Stroke volume variation in the evaluation of fluid responsiveness in refractory septic shock

Hongmin ZHANG ; Dawei LIU ; Xiaoting WANG ; Xi RUI ; Hao WANG ; Huaiwu HE ; Ye LIU ; Xiukai CHEN

Chinese Journal of Internal Medicine 2010;49(7):610-613

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 55 , 1/6 Show Home Prev Next End page: GO